Educational information, not medical advice — ask your doctor or midwife.
Crossopetalum gaumeri is a wild shrub from the Yucatán Peninsula. It grows in southern Mexico, Belize and nearby parts of Central America. It belongs to the staff vine family (Celastraceae).
It shows up on regional lists of medicinal plants. Village healers there have used the leaves, bark or roots in home remedies. It is not a shelf product in most countries, and few people outside the region have heard of it.
Here is the honest verdict. There are no human trials on this plant for any health use.
Traditional use tells you that people used it. It does not tell you that it works, and it does not tell you that it is safe.
That gap matters more than usual here. Many plants have at least a lab study or two behind them. For this one, even the basic chemistry is barely described in the published record.
So this page cannot tell you that it helps anything. It can tell you what is claimed, what is missing, and where the risks sit. If you are weighing it up, treat it as an unknown rather than a mild herb.
No one has shown how this plant acts in the human body. There is no tested mechanism to report.
What exists is family-level chemistry. Plants in the staff vine family often carry sesquiterpenes and triterpenes. Some of these compounds slow inflammation signals in cell studies.
That work was done on other species, not on this one. A shared plant family is a weak clue, not proof. Two plants in the same family can act very differently in people.
Some relatives in this family also carry compounds that irritate the gut or act on the heart. That is a reason for care, not a reason for alarm. It simply means the plant has not earned the label "gentle".
If you read a claim that this shrub "fights inflammation" or "cleanses" something, ask where that came from. For now, the honest answer is that nobody has looked.
In its home range the plant is used fresh or dried, straight from the bush. There is no standard commercial form.
Forms reported in regional use:
- Water decoctions of bark, root or stem - Leaf infusions, drunk or applied to skin - Crushed plant material used as a poultice on the skin
You will rarely find it as a capsule, tincture or powder. When an unusual plant does turn up online, the main risk is the label. Lookalike shrubs are easy to confuse, and a mislabelled product can contain something else entirely.
There is no accepted quality standard for this plant. No testing scheme checks its identity or purity.
Crossopetalum gaumeri has a place in Yucatec folk medicine. Healers in the region treated it as one of many local bush remedies.
It appears in survey lists of Central American medicinal plants. Those surveys record what people used. They did not test whether the plant helped.
The written record is thin. Specific recipes, amounts and treatment lengths were passed on by word of mouth. Much of that detail never reached print.
This page describes that history. It does not suggest you copy it at home.
Stop using it and see a doctor if you get stomach pain, vomiting or diarrhoea that does not settle.
Get medical help the same day if you notice:
- Yellow skin or yellow eyes - Dark urine or much less urine than usual - A spreading rash - Dizziness or a racing heartbeat
Call emergency services for swelling of the lips, throat or tongue, or for trouble breathing. These can be signs of a severe allergic reaction.
Tell the clinician exactly what plant you took, and bring the material or packet with you if you can.
Crossopetalum gaumeri is not approved as a medicine in the United States, the United Kingdom, the European Union, Canada or Australia. In the EU it would count as a novel food and would need authorisation before sale. Where it is used, it is gathered locally rather than sold as a regulated product.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.
